DataConsultant helps healthcare and life-sciences organisations establish clear ownership, quality controls, metadata, lineage, standards and operating discipline across clinical and research data. We connect study and care data flows with governance decisions so teams can improve trust in analysis, safety, evidence generation, regulatory work and responsible data reuse.
Scope, timeline and commercial terms are confirmed after reviewing clinical processes, studies or portfolios, data domains, systems, vendors, regulatory context, evidence and implementation requirements.
Definitions and requirements begin with the study and intended evidence.
Sensitive data, consent and permitted use need explicit governance.
Critical data should be measurable, reviewable and fit for intended use.
Provenance and lineage connect source capture to analysis and outputs.
Ownership, access, quality and controls sustain trustworthy reuse.
Clinical information crosses studies, sites, vendors, laboratories, safety systems, standards pipelines and analytics environments. Without clear accountability and control, data problems surface late—during review, reconciliation, analysis, inspection preparation or downstream reuse.
EDC, central labs, imaging, eCOA, EHR-derived data, safety and external vendors can create disconnected definitions, hand-offs and control boundaries.
Study teams, clinical data management, safety, biostatistics, quality, technology and privacy may each influence the same data without one accountable governance path.
Quality checks can be technically numerous but still weakly connected to critical data, intended use, business impact, accountable owners and remediation.
It may be difficult to explain how a result moved from source capture through cleaning, derivation, standardisation, analysis and a final evidence artefact.
Clinical and patient-linked data may need stronger classification, permitted-use logic, role-based access, de-identification decisions and third-party controls.
Teams can spend significant effort reconstructing evidence, ownership, issue history and control performance when those records are not governed during normal operations.
The target is not a policy document. It is an operating capability in which clinical data ownership, quality, lineage, standards, access and issues are connected to the clinical decisions and evidence they support.
Common patterns that reduce trust and slow decision-making.
A governed, measurable and operationally sustainable clinical data capability.
Start with the studies, domains, data flows, quality issues and governance decisions that create the greatest operational, evidence or control concern.
Governance should follow real clinical work—from protocol intent and source capture through review, standards conversion, analysis, evidence generation and controlled reuse.
Define endpoints, data requirements, standards and critical information.
Establish identifiers, consent context, site roles and source expectations.
Receive EDC, lab, imaging, eCOA, device and external data feeds.
Apply checks, queries, reconciliation, issue workflows and remediation.
Map terminology, structures and metadata for consistent downstream use.
Derive analysis-ready datasets with controlled transformations and lineage.
Support safety, study decisions, evidence outputs and regulatory work.
Govern retention, permitted reuse, research access and future analytics.
A study links protocol intent, sites, subjects, interventions, observations, safety and analytical outputs. Governance becomes practical when those relationships are explicit and ownership follows the way data is actually produced and consumed.
The service combines governance design with the data, quality, metadata, architecture and operating mechanisms needed to make accountability usable in day-to-day clinical work.
DataConsultant can map the governance requirements that should operate across source capture, integration, standardisation, analysis and downstream use. The exact platforms remain client-specific and requirements-led.
EDC/eCRF, labs, imaging, eCOA/ePRO, devices, safety, EHR/RWD and approved external data.
APIs, files, integration, reconciliation, validation, monitoring and source metadata capture.
Study structures, terminology, curated domains, standardisation, metadata and governed transformations.
Analysis datasets, statistics, analytics, evidence artefacts and controlled research environments.
Study decisions, safety insight, reporting, evidence generation, responsible reuse and AI-ready data foundations.
Connect critical endpoints and study data to definitions, rules, issue thresholds, owners and monitoring so governance follows study importance.
Standardise quality logic where appropriate while retaining study-specific context, exceptions and accountable review.
Clarify data ownership, matching logic, exceptions, evidence and escalation where clinical and safety data intersect.
Define metadata and lineage needed to understand important transformations from collection through standardisation and analysis.
Assess provenance, quality, permitted use, coding, mapping and fitness for purpose before external healthcare data enters research workflows.
Establish documented provenance, quality, access, intended-use and accountability foundations before data supports model development or AI-assisted workflows.
Clarify where data originates, how it changes, who is accountable and which evidence matters. Then define catalogue, lineage, quality or workflow tooling around real clinical requirements.
Clinical data crosses scientific, operational, technology and control functions. The operating model should make those intersections explicit instead of assigning “data governance” to one central team.
Regulatory and standards requirements depend on jurisdiction, product, study, role, data handled and intended use. DataConsultant can translate applicable obligations into data ownership, traceability, quality, access and evidence requirements without presenting governance as a substitute for legal or regulatory advice.
Consider quality-by-design, reliable trial information, fit-for-purpose systems and proportionate control when defining clinical data governance responsibilities and evidence.
Review official ICH efficacy guidelinesWhere Part 11 applies, governance should account for electronic records, controls, auditability and the systems or processes used to create, modify, maintain, archive, retrieve or transmit regulated records.
Review FDA Part 11 scope and application guidanceFor applicable EU clinical trials, governance may need to support data, document and evidence responsibilities connected with the Clinical Trials Regulation and Clinical Trials Information System.
Review EMA Clinical Trials Regulation informationFor relevant clinical-trial or new-drug activity in India, the New Drugs and Clinical Trials Rules, 2019 and current CDSCO processes may influence governance, records and evidence requirements.
Review official CDSCO rules and informationWhere applicable, clinical-data governance should account for India’s DPDP framework and the notified commencement schedule when defining personal-data purpose, access, sharing and accountability.
Review official DPDP Rules 2025CDISC can support structured clinical research data and metadata, while HL7 FHIR can support interoperable healthcare data exchange. Governance should define where each standard applies, who owns mappings and how exceptions are controlled.
Review CDISC foundational standardsThe engagement is run as a consulting and capability-design programme: evidence first, decision rights second, then implementation. The sequence is adjusted to the organisation’s study portfolio, governance maturity, systems and risk context.
Confirm sponsor objectives, clinical processes, stakeholders, evidence and constraints.
Map studies, data domains, systems, vendors, flows, decisions and control boundaries.
Identify critical data, recurring quality issues, traceability gaps and governance risks.
Define roles, decision rights, standards, quality controls, metadata and operating forums.
Test the model against real study scenarios, exceptions, evidence needs and user workflows.
Create the implementation backlog, ownership plan, tooling requirements and change plan.
Launch forums, stewardship, issue workflows, reporting and governance routines.
Review metrics, root causes, adoption and controls; then scale or transfer capability.
The roadmap is sequenced by decision gates and dependencies rather than by an invented fixed duration. Timeline is confirmed after scoping and evidence review.
Confirm clinical scope, priority studies or domains, pain points, obligations and evidence gaps.
Gate: priority scope agreedDefine domains, accountable owners, stewards, decision rights and governance interfaces.
Gate: accountability approvedIdentify critical data, definitions, rules, metadata, lineage and exception requirements.
Gate: control design acceptedEstablish forums, policies, issue workflow, reporting, tooling requirements and change process.
Gate: operating model readyOnboard roles, configure workflows, enable metadata and quality controls, and train teams.
Gate: capability operationalMonitor issues, quality, adoption and evidence; refine the model and extend to more portfolios.
Gate: scale / transfer decisionOutputs are selected according to the decisions and implementation scope. A focused assessment will not automatically include every deliverable below.
Evidence-based maturity, gap and risk findings across clinical data governance.
Mapped relationships between studies, domains, sources, transformations and uses.
Accountable owners, stewards, contributors, decision rights and escalation.
Prioritised data elements linked to intended use, definitions and business impact.
Rules, dimensions, controls, thresholds, exceptions and accountable remediation.
Traceability requirements for important source, standardisation and analysis flows.
Principles, policy structure, standards, decision forums and issue governance.
Roles, interactions, service boundaries, cadence, reporting and change ownership.
Sequenced actions, dependencies, decision gates and mobilisation priorities.
Metrics, evidence, issue reporting and management views for sustained oversight.
The most useful evidence depends on scope. DataConsultant records missing evidence as a limitation rather than assuming facts about the clinical data estate.
Translate roles, critical data, quality controls, metadata, lineage and governance forums into sequenced work that clinical, data, technology and quality teams can execute.
The engagement does not need to stop at assessment. Implementation and operational support can be scoped separately so governance becomes part of normal clinical-data work.
Programme setup, governance launch, owner and steward onboarding, policy activation, issue workflow and implementation assurance.
Metadata and lineage requirements, catalogue workflows, quality-control implementation, platform advisory and integration with existing tooling.
Forums, stewardship, issue management, standards changes, control reporting, quality monitoring and improvement backlog support.
Rule monitoring, exceptions, root-cause triage, remediation coordination and reporting for priority clinical data.
Prepare governed clinical data foundations and connect them to separate AI-use-case, model-risk, evaluation and human-oversight controls where required.
Role-based training, operating playbooks, governance coaching and transition support so internal teams can sustain the capability.
The value comes from making clinical data responsibilities and controls usable in operational and scientific decisions—not from governance artefacts in isolation.
Teams know who can define, approve, change, accept risk and resolve issues for important clinical data.
Critical data is tied to measurable rules, impact, exception handling and accountable remediation.
Metadata and lineage make important transformations and dependencies easier to understand and review.
Common standards, controls and decision processes can be reused while retaining study-specific context.
Classification, access, purpose and third-party responsibilities are made explicit for sensitive clinical information.
Mappings, terminology and exchange standards have ownership, exceptions and change processes.
Clinical data provenance, quality and permitted use are clearer before advanced analytics or AI is introduced.
Issues, evidence, stewardship and reporting become part of the operating cadence rather than inspection-time reconstruction.
DataConsultant does not publish a fixed fee for this service. Clinical data governance pricing is confirmed through a scoped proposal after the required decisions, data estate, stakeholders, controls and implementation depth are understood.
Engagements may be structured as a focused diagnostic, governance design project, implementation mobilisation, retained advisory engagement or ongoing governance-operation support. The commercial model is agreed for the actual scope; third-party platform, cloud or licence costs are separate unless explicitly included.
Timeline: confirmed after scoping. No fixed duration is implied by the engagement type.
Request a Scoped ProposalUse the service when the problem spans accountability, clinical data flows, quality, metadata, standards and operating controls. Choose a narrower service when the need is limited to one technical or data-management capability.
Credibility comes from how the work is structured: clinical context is connected to data architecture, governance, quality, metadata, risk and implementation rather than treated as a standalone policy exercise.
Study, subject, safety, clinical observations and analysis are treated as connected business and data domains.
Ownership and controls are designed around real source, integration, transformation and evidence flows.
Quality rules, issues and remediation are tied to critical data, intended use and accountable decisions.
Metadata, provenance and lineage are linked to decisions, impact analysis and evidence needs.
Sensitive data, access, permitted use, third parties and evidence requirements are considered from the start.
Design outputs can be converted into mobilisation, controls, tooling requirements, governance operations and knowledge transfer.
Share the governance decision, study or portfolio context, data domains and main control concerns. DataConsultant can define a scoped assessment, design or implementation engagement.
Practical answers for healthcare and life-sciences buyers evaluating governance scope, delivery, implementation and operating support.
Provide enough context for DataConsultant to understand the requirement. Please do not include patient identifiers, research-subject information, credentials or other highly sensitive data in this form.
